Explore the words cloud of the OncoViroMRI project. It provides you a very rough idea of what is the project "OncoViroMRI" about.
The following table provides information about the project.
TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD
|Coordinator Country||Israel [IL]|
|Total cost||269˙998 €|
|EC max contribution||269˙998 € (100%)|
1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
|Duration (year-month-day)||from 2019-11-01 to 2022-10-31|
Take a look of project's partnership.
|1||TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD||IL (HAIFA)||coordinator||269˙998.00|
|2||Athinoula A. Martinos Center for Biomedical Imaging||US (Charlestown)||partner||0.00|
Glioblastoma multiforme (GBM) is the most common type of brain tumor found in adults and is fatal in all cases. A very promising therapeutic approach for GBM is the use of oncolytic viruses (OVs) that selectively infect, replicate in, and destroy tumor cells, while sparing the surrounding normal cells. Nevertheless, to achieve successful oncolytic virotherapy, frequent non-invasive monitoring of the process must be performed. This is crucial for gaining a better understanding of the interactions between the virus and its tumor-host and predicting a therapeutic response. Thus, the development of a non-invasive method, capable of accurately quantifying the location and extent of the viral spread in the tumor is highly required and is of great importance. Accordingly, the main research goal of this action is to develop a magnetic resonance imaging (MRI)- based method for accurate, quantitative, and rapid imaging of OVs delivery, and spread in clinically relevant tumor models. The devised interdisciplinary methodology includes: genetically modifying the therapeutic virus to be detectable in MRI; developing machine learning methods to increase the speed, specificity, and sensitivity in image-monitoring the virus; and evaluating the established methods using mice models of brain tumor therapy. The allocated training and research environment is optimal for achieving the proposal goals: an outgoing phase at Harvard Medical School, a secondment at a leading clinical MRI company (Insightec), enhancing translation potential, and a return phase at a leading university (Technion), ensuring the transport of knowledge back to the EU. The envisioned technology could be expanded to various additional clinical conditions, and its dissemination could improve patient care. The unique skill set to be acquired by the experienced researcher, would allow claiming a distinct niche of knowledge, increasing competency to a tenure-track position, and a research career in the EU.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ONCOVIROMRI" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "ONCOVIROMRI" are provided by the European Opendata Portal: CORDIS opendata.
Two Are Better Than One: Bimetallic Catalysts for the Conversion of Lignin-Derived Aryl-EthersRead More
New treatments and novel diagnostic tests for neonatal seizures based on purinergic signaling.Read More
Cholinergic and NMDAR-dependent recruitment of Layer 1 Interneuron shapes cortical motor Processing through network States ModulationRead More